Report Detail

Request for Sample of this report

Chemical & Material Global Decitabine API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4638799
    • |
  • 24 October, 2025
    • |
  • Global
    • |
  • 113 Pages
    • |
  • GIR
    • |
  • Chemical & Material

According to our (Global Info Research) latest study, the global Decitabine API market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Decitabine is a cytosine analogue and an intravenously administered antineoplastic agent used in the therapy of myelodysplastic syndromes. Decitabine is associated with a low rate of transient serum enzyme elevations during therapy, but has not been implicated in causing clinically apparent liver injury with jaundice.
This report is a detailed and comprehensive analysis for global Decitabine API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Decitabine API market size and forecasts, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
Global Decitabine API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
Global Decitabine API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
Global Decitabine API market shares of main players, shipments in revenue ($ Million), sales quantity (Ton), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Decitabine API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Decitabine API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Dr. Reddy’s Laboratories Ltd., Biophore India Pharmaceuticals, Tecoland Corporation, Johnson Matthey PLC, Farmhispania, S.A., VShilpa Medicare Limitedbshilpa, Wuhan Calmland Pharmaceuticals Co.,Ltd, ScinoPharm Taiwan, Ltd, Zhejiang Hisun Pharmaceutical, Mac-Chem Products (India) Pvt.Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Decitabine API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity≥98%
Purity<98%
Market segment by Application
Decitabine Injections
Others
Major players covered
Dr. Reddy’s Laboratories Ltd.
Biophore India Pharmaceuticals
Tecoland Corporation
Johnson Matthey PLC
Farmhispania, S.A.
VShilpa Medicare Limitedbshilpa
Wuhan Calmland Pharmaceuticals Co.,Ltd
ScinoPharm Taiwan, Ltd
Zhejiang Hisun Pharmaceutical
Mac-Chem Products (India) Pvt.Ltd
Synthland Limited
Hanways Chempharm Co., Limited
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Decitabine API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Decitabine API, with price, sales quantity, revenue, and global market share of Decitabine API from 2020 to 2025.
Chapter 3, the Decitabine API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Decitabine API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Decitabine API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Decitabine API.
Chapter 14 and 15, to describe Decitabine API sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Decitabine API Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Purity≥98%
    • 1.3.3 Purity<98%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Decitabine API Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Decitabine Injections
    • 1.4.3 Others
  • 1.5 Global Decitabine API Market Size & Forecast
    • 1.5.1 Global Decitabine API Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Decitabine API Sales Quantity (2020-2031)
    • 1.5.3 Global Decitabine API Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Dr. Reddy’s Laboratories Ltd.
    • 2.1.1 Dr. Reddy’s Laboratories Ltd. Details
    • 2.1.2 Dr. Reddy’s Laboratories Ltd. Major Business
    • 2.1.3 Dr. Reddy’s Laboratories Ltd. Decitabine API Product and Services
    • 2.1.4 Dr. Reddy’s Laboratories Ltd. Decitabine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Dr. Reddy’s Laboratories Ltd. Recent Developments/Updates
  • 2.2 Biophore India Pharmaceuticals
    • 2.2.1 Biophore India Pharmaceuticals Details
    • 2.2.2 Biophore India Pharmaceuticals Major Business
    • 2.2.3 Biophore India Pharmaceuticals Decitabine API Product and Services
    • 2.2.4 Biophore India Pharmaceuticals Decitabine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Biophore India Pharmaceuticals Recent Developments/Updates
  • 2.3 Tecoland Corporation
    • 2.3.1 Tecoland Corporation Details
    • 2.3.2 Tecoland Corporation Major Business
    • 2.3.3 Tecoland Corporation Decitabine API Product and Services
    • 2.3.4 Tecoland Corporation Decitabine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Tecoland Corporation Recent Developments/Updates
  • 2.4 Johnson Matthey PLC
    • 2.4.1 Johnson Matthey PLC Details
    • 2.4.2 Johnson Matthey PLC Major Business
    • 2.4.3 Johnson Matthey PLC Decitabine API Product and Services
    • 2.4.4 Johnson Matthey PLC Decitabine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Johnson Matthey PLC Recent Developments/Updates
  • 2.5 Farmhispania, S.A.
    • 2.5.1 Farmhispania, S.A. Details
    • 2.5.2 Farmhispania, S.A. Major Business
    • 2.5.3 Farmhispania, S.A. Decitabine API Product and Services
    • 2.5.4 Farmhispania, S.A. Decitabine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Farmhispania, S.A. Recent Developments/Updates
  • 2.6 VShilpa Medicare Limitedbshilpa
    • 2.6.1 VShilpa Medicare Limitedbshilpa Details
    • 2.6.2 VShilpa Medicare Limitedbshilpa Major Business
    • 2.6.3 VShilpa Medicare Limitedbshilpa Decitabine API Product and Services
    • 2.6.4 VShilpa Medicare Limitedbshilpa Decitabine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 VShilpa Medicare Limitedbshilpa Recent Developments/Updates
  • 2.7 Wuhan Calmland Pharmaceuticals Co.,Ltd
    • 2.7.1 Wuhan Calmland Pharmaceuticals Co.,Ltd Details
    • 2.7.2 Wuhan Calmland Pharmaceuticals Co.,Ltd Major Business
    • 2.7.3 Wuhan Calmland Pharmaceuticals Co.,Ltd Decitabine API Product and Services
    • 2.7.4 Wuhan Calmland Pharmaceuticals Co.,Ltd Decitabine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Wuhan Calmland Pharmaceuticals Co.,Ltd Recent Developments/Updates
  • 2.8 ScinoPharm Taiwan, Ltd
    • 2.8.1 ScinoPharm Taiwan, Ltd Details
    • 2.8.2 ScinoPharm Taiwan, Ltd Major Business
    • 2.8.3 ScinoPharm Taiwan, Ltd Decitabine API Product and Services
    • 2.8.4 ScinoPharm Taiwan, Ltd Decitabine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 ScinoPharm Taiwan, Ltd Recent Developments/Updates
  • 2.9 Zhejiang Hisun Pharmaceutical
    • 2.9.1 Zhejiang Hisun Pharmaceutical Details
    • 2.9.2 Zhejiang Hisun Pharmaceutical Major Business
    • 2.9.3 Zhejiang Hisun Pharmaceutical Decitabine API Product and Services
    • 2.9.4 Zhejiang Hisun Pharmaceutical Decitabine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
  • 2.10 Mac-Chem Products (India) Pvt.Ltd
    • 2.10.1 Mac-Chem Products (India) Pvt.Ltd Details
    • 2.10.2 Mac-Chem Products (India) Pvt.Ltd Major Business
    • 2.10.3 Mac-Chem Products (India) Pvt.Ltd Decitabine API Product and Services
    • 2.10.4 Mac-Chem Products (India) Pvt.Ltd Decitabine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Mac-Chem Products (India) Pvt.Ltd Recent Developments/Updates
  • 2.11 Synthland Limited
    • 2.11.1 Synthland Limited Details
    • 2.11.2 Synthland Limited Major Business
    • 2.11.3 Synthland Limited Decitabine API Product and Services
    • 2.11.4 Synthland Limited Decitabine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Synthland Limited Recent Developments/Updates
  • 2.12 Hanways Chempharm Co., Limited
    • 2.12.1 Hanways Chempharm Co., Limited Details
    • 2.12.2 Hanways Chempharm Co., Limited Major Business
    • 2.12.3 Hanways Chempharm Co., Limited Decitabine API Product and Services
    • 2.12.4 Hanways Chempharm Co., Limited Decitabine API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Hanways Chempharm Co., Limited Recent Developments/Updates

3 Competitive Environment: Decitabine API by Manufacturer

  • 3.1 Global Decitabine API Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Decitabine API Revenue by Manufacturer (2020-2025)
  • 3.3 Global Decitabine API Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Decitabine API by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Decitabine API Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Decitabine API Manufacturer Market Share in 2024
  • 3.5 Decitabine API Market: Overall Company Footprint Analysis
    • 3.5.1 Decitabine API Market: Region Footprint
    • 3.5.2 Decitabine API Market: Company Product Type Footprint
    • 3.5.3 Decitabine API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Decitabine API Market Size by Region
    • 4.1.1 Global Decitabine API Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Decitabine API Consumption Value by Region (2020-2031)
    • 4.1.3 Global Decitabine API Average Price by Region (2020-2031)
  • 4.2 North America Decitabine API Consumption Value (2020-2031)
  • 4.3 Europe Decitabine API Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Decitabine API Consumption Value (2020-2031)
  • 4.5 South America Decitabine API Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Decitabine API Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Decitabine API Sales Quantity by Type (2020-2031)
  • 5.2 Global Decitabine API Consumption Value by Type (2020-2031)
  • 5.3 Global Decitabine API Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Decitabine API Sales Quantity by Application (2020-2031)
  • 6.2 Global Decitabine API Consumption Value by Application (2020-2031)
  • 6.3 Global Decitabine API Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Decitabine API Sales Quantity by Type (2020-2031)
  • 7.2 North America Decitabine API Sales Quantity by Application (2020-2031)
  • 7.3 North America Decitabine API Market Size by Country
    • 7.3.1 North America Decitabine API Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Decitabine API Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Decitabine API Sales Quantity by Type (2020-2031)
  • 8.2 Europe Decitabine API Sales Quantity by Application (2020-2031)
  • 8.3 Europe Decitabine API Market Size by Country
    • 8.3.1 Europe Decitabine API Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Decitabine API Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Decitabine API Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Decitabine API Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Decitabine API Market Size by Region
    • 9.3.1 Asia-Pacific Decitabine API Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Decitabine API Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Decitabine API Sales Quantity by Type (2020-2031)
  • 10.2 South America Decitabine API Sales Quantity by Application (2020-2031)
  • 10.3 South America Decitabine API Market Size by Country
    • 10.3.1 South America Decitabine API Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Decitabine API Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Decitabine API Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Decitabine API Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Decitabine API Market Size by Country
    • 11.3.1 Middle East & Africa Decitabine API Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Decitabine API Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Decitabine API Market Drivers
  • 12.2 Decitabine API Market Restraints
  • 12.3 Decitabine API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Decitabine API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Decitabine API
  • 13.3 Decitabine API Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Decitabine API Typical Distributors
  • 14.3 Decitabine API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Decitabine API. Industry analysis & Market Report on Decitabine API is a syndicated market report, published as Global Decitabine API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Decitabine API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo